Dominant frontonasal dysplasia with ectodermal defects results from increased activity of ALX4

Am J Med Genet A. 2023 Dec;191(12):2806-2812. doi: 10.1002/ajmg.a.63408. Epub 2023 Sep 19.

Abstract

Frontonasal dysplasia (FND) refers to a group of rare developmental disorders characterized by abnormal morphology of the craniofacial region. We studied a family manifesting with clinical features typical for FND2 including neurobehavioral abnormalities, hypotrichosis, hypodontia, and facial dysmorphism. Whole-exome sequencing analysis identified a novel heterozygous frameshift insertion in ALX4 (c.985_986insGTGC, p.Pro329Argfs*115), encoding aristaless homeobox 4. This and a previously reported dominant FND2-causing variant are predicted to result in the formation of a similar abnormally elongated protein tail domain. Using a reporter assay, we showed that the elongated ALX4 displays increased activity. ALX4 negatively regulates the Wnt/β-catenin pathway and accordingly, patient keratinocytes showed altered expression of genes associated with the WNT/β-catenin pathway, which in turn may underlie ectodermal manifestations in FND2. In conclusion, dominant FND2 with ectodermal dysplasia results from frameshift variants in ALX4 exerting a gain-of-function effect.

Keywords: ALX4; ectodermal dysplasia; frameshift; frontonasal dysplasia; genodermatosis; hypotrichosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Craniofacial Abnormalities* / genetics
  • DNA-Binding Proteins / genetics
  • Ectodermal Dysplasia* / genetics
  • Face
  • Genes, Homeobox
  • Humans
  • Transcription Factors / genetics
  • beta Catenin / genetics

Substances

  • beta Catenin
  • ALX4 protein, human
  • DNA-Binding Proteins
  • Transcription Factors

Supplementary concepts

  • Frontonasal dysplasia